Akebia Therapeutics, Inc.
Ownership
Ownership Structure
Who owns Akebia Therapeutics, Inc. (AKBA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.2% of the shares are freely tradable; institutional investors hold 42.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 7.21 | 19,986,374 | +6.9 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.09 | 11,322,143 | +1.4 | 06/30/2026 |
| AQR Capital Management LLC | 3.30 | 9,151,524 | +410.5 | 06/30/2026 |
| Geode Capital Management, LLC | 2.43 | 6,727,302 | +4.3 | 06/30/2026 |
| State Street Corp | 1.95 | 5,390,853 | -53.6 | 06/30/2026 |
| Jacobs Levy Equity Management, Inc. | 1.54 | 4,273,026 | +894.5 | 06/30/2026 |
| Acadian Asset Management LLC | 1.45 | 4,004,867 | +190.8 | 06/30/2026 |
| Nantahala Capital Management, LLC | 1.44 | 4,000,000 | +100.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.86 | 7,912,283 | +0.0 | 09/30/2026 |
| iShares Russell 2000 ETF | 2.46 | 6,827,065 | -1.1 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Butler John P. | CEO and President | 3,718,564 | 2,627,165 $ | Aug 6, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Butler John P. | CEO and President | Other | 350,000 | 0.63 | 220,500 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.